News & Updates

The early addition of ivermectin to standard of care (SoC)* in high-risk patients with mild-to-moderate COVID-19 did not prevent progression to severe disease compared with SoC alone, according to results of the I-TECH** trial conducted in Malaysia.

No apparent association exists between neuropsychiatric systemic lupus erythematosus (NPSLE) and known risk loci for schizophrenia in a multiethnic cohort of patients with childhood-onset (c)SLE, reveals a recent study.

Consultants and nurses usually focus their efforts on treating cancer and minimizing treatment-related side effects. However, cancer side effects are not merely confined to bodily manifestations, but also include emotional and psychological aspects.